The stakes are different
Medical and pharmaceutical translation covers documents where a mistranslation could affect patient safety or regulatory approval — clinical trial protocols, informed consent forms, package inserts (bulas), and pharmacovigilance reports all require careful, domain-aware translation.
Regulatory context in Brazil
Companies submitting pharmaceutical documentation in Brazil typically work within ANVISA's regulatory framework; international submissions may also need to align with agencies like the FDA. Translators working on this content benefit from familiarity with the relevant regulatory terminology.
Working with subject-matter translators
Medical and pharmaceutical documents benefit from translators with relevant subject-matter background, not just language fluency — terminology consistency across a large dossier is as important as any individual sentence.
Key takeaways
- Medical translation carries higher stakes than general business content.
- Brazil submissions typically involve ANVISA; international ones may involve the FDA.
- Subject-matter familiarity matters as much as language skill for this content.
Need help with this?
From clinical protocols to package inserts, medical translation has little tolerance for error.